Patent 7432096 was granted and assigned to Bayer on October, 2008 by the United States Patent and Trademark Office.
The invention relates to novel PQQ-dependent soluble glucose dehydrogenases (sPQQGDH) from Acinetobacter and to a process for their preparation by overexpression in suitable microbial expression systems.